| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-27 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $52.85B | $53.10B | $54.23B |
| YoY Revenue Growth % | -0.5% | -2.1% | — |
| Gross Profit | $18.38B | $17.34B | — |
| Gross Margin % | 34.8% | 32.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.21B | -$11.68B | $93.0M |
| Operating Margin % | -4.2% | -22.0% | 0.2% |
| Net Income (GAAP) | -$267.0M | -$18.76B | $1.69B |
| EBITDA (Normalized) | $9.50B | $7.48B | $2.05B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $9.70B | $8.29B | $11.47B |
| Capital Expenditures (CapEx) | $14.65B | $23.94B | $2.44B |
| Free Cash Flow (FCF) | -$4.95B | -$15.66B | $9.03B |
| FCF Margin % | -9.4% | -29.5% | 16.7% |
| Return on Invested Capital (ROIC %) | -1.2% | -6.7% | 0.0% |
| Cash & Short-Term Equivalents | $14.27B | $8.25B | — |
| Total Debt (Short + Long Term) | $44.09B | $46.28B | $62.62B |
| Total Stockholders' Equity | $114.28B | $99.27B | $128.46B |